يحاول ذهب - حر
Clinical trials for generics proposed
October 11, 2025
|Financial Express Mumbai
EVEN AS INDIAN drug-makers have heaved a sigh of relief with the United States' decision to shelve the plan to extend the tariff hikes to generic medicines, a key change is in the offing in domestic regulations that will spell trouble for them.
The country's drug regulator - Central Drugs Standard Control Organisation (CDSCO) - has proposed to close the easy route for pharmaceutical companies to quickly launch generic versions of "new drugs" by just proving that these are bio-equivalent to the innovators' drugs.
Experts said that the move has come in the wake of growing pressure from the Donald Trump administration to reduce the non-tariff barriers for US companies in India.
IF THE PROPOSAL, made in a "note for public comments" released by CDSCO, is converted into a rule, the launch of generic drugs will also require submission of separate data on clinical trials, just as the "new drugs" do. Clinical trials are much more expensive and time-consuming than the bioequivalence studies. Currently, once a new drug is approved based on clinical trials and BE data, the generic companies simultaneously submit the BE study report with the regulator, and obtain approval for their version of the drug.
However, this puts the innovator company at a disadvantageous position as there is a lack of level-playing field, the CDSCO said in the note.
هذه القصة من طبعة October 11, 2025 من Financial Express Mumbai.
اشترك في Magzter GOLD للوصول إلى آلاف القصص المتميزة المنسقة، وأكثر من 9000 مجلة وصحيفة.
هل أنت مشترك بالفعل؟ تسجيل الدخول
المزيد من القصص من Financial Express Mumbai
Financial Express Mumbai
World awaits blowback as Nobel slips from Trump's hands
IN AWARDING THE Peace Prize to Maria Corina Machado of Venezuela, the Norwegian Nobel Committee recognised \"a woman who keeps the flame of democracy burning amid a growing darkness.
2 mins
October 11, 2025
Financial Express Mumbai
Israel-Hamas ceasefire deal: Impact on global trade, India’s economic interests
THE SHARES OF global shipping giant Maersk, seen as a barometer of world trade, hit a three-month low on Thursday after Israel and Hamas agreed to a long-awaited ceasefire and hostage release deal that could end the two-year-long bloody conflict in Gaza.
2 mins
October 11, 2025
Financial Express Mumbai
On 5-day trip to India, new US envoy to meet top ministers, officials
DAYS AFTER HIS appointment as the US Ambassador to India was confirmed by the Senate, Sergio Gor is travelling to India for five days.
2 mins
October 11, 2025
Financial Express Mumbai
OMCs expected to register sequential dip in Q2FY26
STATE-RUN OIL marketing companies (OMCs) are likely to report a sequential decline in earnings for the July-September quarter of FY26 (Q2FY26),as rising crude prices and stable retail fuel prices put pressure on marketing margins.
2 mins
October 11, 2025
Financial Express Mumbai
Conflict of interest panel report likely next week: Pandey
THE HIGH-LEVEL COMMITTEE tasked with comprehensively reviewing the Securities and Exchange Board of India's conflict of interest norms for its board members and executives and suggesting new guidelines will \"certainly\" submit its report this month, Sebi Chairman Tuhin Kanta Pandey told FE.
1 mins
October 11, 2025
Financial Express Mumbai
UK triggers new powers to regulate Google search
GOOGLE COULD BE forced to change its search operations in the UKafter it became the first company subject to new powers from Britain’s competition regulator to tackle the dominance of Big Tech.
1 min
October 11, 2025

Financial Express Mumbai
Fresh bid to privatise power distribution
Centre releases Draft Electricity Amendment Bill
3 mins
October 11, 2025
Financial Express Mumbai
US sanctions 9 Indian firms, 8 nationals
AS PART OF its campaign of maximum economic pressure on Iran, the US has sanctioned nine India-based companies and eight Indian nationals as part of its latest Iran-related sanctions action, alleging that they have been engaged in trade of Iranian oil, petroleum products, and petrochemicals.
2 mins
October 11, 2025
Financial Express Mumbai
Fintechs pivoting to blended portfolio to lower risk : BCG
FINANCIAL TECHNOLOGY COMPANIES (fintechs) in India are recalibrating their lending strategies, shifting from highyield, unsecured loans to a blended portfolio that includes secured lending-a move aimed at lowering the cost of capital and improving credit quality, Yashraj Erande, global leader, fintech; India leader-financial institutions at Boston Consulting Group (BCG) said.
1 min
October 11, 2025
Financial Express Mumbai
Funding slump continues as fintech startups raise $1.6 bn
WHILE THE YEAR began with a modest rebound in startup funding, the momentum hasn't lasted long.
1 mins
October 11, 2025
Listen
Translate
Change font size